Roche’s virtual event at the 2022 ASCO Annual Meeting focusing on the oncology pipeline
Roche has hosted a virtual event on Monday, 6 June 2022.
| Agenda | |
|---|---|
| Oncology late-stage portfolio update | Elena Bernedo-Arzac, SVP, Oncology Therapeutic Area Head |
| Key Data at ASCO 2022 - Glofitamab pivotal Ph1b data in 3L+DLBCL - Polivy Asian sub-population data from Ph3 POLARIX in 1L DLBCL | Ginna Laporte, MD VP, Global Head Lymphoma/CLL Clinical Development |
| Oncology early R&D update | Johanna Bendell, M.D., Head of Roche Pharma Research and Early Development (pRED) Oncology Andy Chan, M.D., Ph.D. Senior Vice President, Research Biology, Genentech Research & Early Development (gRED) |
| Q&A |